Fig. 2From: Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013–2018Quarterly Rates of HBOC, Lynch Syndrome, Tier 2 Molecular Pathology Procedures*, and Any** Cancer Genetic Testing, Stratified by Age and Sex. HBOC – Hereditary Breast and Ovarian Cancer. * Tier 2 molecular pathology procedures are based on the complexity of the testing technique and are not specific to a gene or hereditary cancer syndrome. ** Any cancer genetic testing included tests in the HBOC, Lynch syndrome, Tier 2 molecular pathology procedures, and other hereditary cancer syndrome (HCS) panel categoriesBack to article page